Literature DB >> 16846479

Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia.

Hiromasa Yabe1, Hiroyasu Inoue, Masae Matsumoto, Satoshi Hamanoue, Takashi Koike, Hiroyuki Ishiguro, Hideki Koike, Kazuo Suzuki, Shunichi Kato, Seiji Kojima, Masahiro Tsuchida, Tetsuya Mori, Souichi Adachi, Koichiro Tsuji, Kenichi Koike, Akira Morimoto, Masahiro Sako, Miharu Yabe.   

Abstract

A pilot study was undertaken using a fludarabine-based conditioning regimen to improve haematopoietic cell transplantation (HCT) from alternative donors in 27 Fanconi anaemia (FA) patients. Patients were conditioned with 150-180 mg/m2 of fludarabine, 40 mg/kg of cyclophosphamide, 5-10 mg/kg of antithymocyte globulin, and 300-450 cGy of thoracoabdominal/total body irradiation. One patient who received unrelated cord blood transplantation failed to engraft, another patient died of sepsis. The 1-year overall survival was 96.3% (95% CI, 89-100). This conditioning regimen exerted an immunosuppressive effect that enabled durable engraftment in alternative donor HCT without severe toxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16846479     DOI: 10.1111/j.1365-2141.2006.06128.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  Fanconi anemia in infancy: report of hematopoietic stem cell transplantation to a 13-month-old patient.

Authors:  Koichi Oshima; Akira Kikuchi; Shinji Mochizuki; Daisuke Toyama; Naoki Uchisaka; Miharu Yabe; Ryoji Hanada
Journal:  Int J Hematol       Date:  2009-05-19       Impact factor: 2.490

2.  Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.

Authors:  Takehiko Mori; Hideo Koh; Yasushi Onishi; Shinichi Kako; Makoto Onizuka; Heiwa Kanamori; Yukiyasu Ozawa; Chiaki Kato; Hiroatsu Iida; Ritsuro Suzuki; Tatsuo Ichinohe; Yoshinobu Kanda; Tetsuo Maeda; Shinji Nakao; Hirohito Yamazaki
Journal:  Int J Hematol       Date:  2016-02-24       Impact factor: 2.490

3.  Natural pregnancy and delivery after unrelated bone marrow transplantation using fludarabine-based regimen in a Fanconi anemia patient.

Authors:  Hiromasa Yabe; Takashi Koike; Takashi Shimizu; Hiroyuki Ishiguro; Tsuyoshi Morimoto; Hiromi Hyodo; Takeshi Akiba; Shunichi Kato; Miharu Yabe
Journal:  Int J Hematol       Date:  2010-02-04       Impact factor: 2.490

Review 4.  Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations.

Authors:  Christen L Ebens; Margaret L MacMillan; John E Wagner
Journal:  Expert Rev Hematol       Date:  2016-12-21       Impact factor: 2.929

5.  Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.

Authors:  J Pietzner; B M Merscher; P C Baer; R P Duecker; O Eickmeier; D Fußbroich; P Bader; D Del Turco; R Henschler; S Zielen; R Schubert
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

Review 6.  Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.

Authors:  Jean-Hugues Dalle; Régis Peffault de Latour
Journal:  Int J Hematol       Date:  2016-02-12       Impact factor: 2.490

7.  Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation.

Authors:  M S Thakar; P Kurre; R Storb; M Kletzel; H Frangoul; M A Pulsipher; W Leisenring; M E D Flowers; B M Sandmaier; A Woolfrey; H-P Kiem
Journal:  Bone Marrow Transplant       Date:  2010-06-28       Impact factor: 5.483

8.  In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation.

Authors:  Miharu Yabe; Hiromasa Yabe; Satoshi Hamanoue; Hiroyasu Inoue; Masae Matsumoto; Takashi Koike; Hiroyuki Ishiguro; Tsuyoshi Morimoto; Satoshi Arakawa; Toshio Ohshima; Atsuko Masukawa; Hayato Miyachi; Takayuki Yamashita; Shunichi Katob
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

9.  Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.

Authors:  M S Thakar; C Bonfim; B M Sandmaier; P O'Donnell; L Ribeiro; T Gooley; H J Deeg; M E Flowers; R Pasquini; R Storb; A E Woolfrey; H P Kiem
Journal:  Pediatr Hematol Oncol       Date:  2012-07-27       Impact factor: 1.969

10.  A 15-year-old girl with pancytopenia and congenital defects.

Authors:  Ahmed M AlSuliman; Kafiah Al Qadaiub
Journal:  Ann Saudi Med       Date:  2009 Jul-Aug       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.